期刊文献+

免充气经腋窝入路腔镜下甲状腺微小乳头状癌手术疗效评价 被引量:10

Effect evaluation of endoscopic surgery for papillary thyroid microcarcinoma through axillary approach without inflation
下载PDF
导出
摘要 目的:探讨免充气经腋窝入路治疗甲状腺微小乳头状癌的手术经验及疗效。方法:选取80例甲状腺微小乳头状癌病人,其中行腔镜手术35例(腔镜组),开放手术45例(开放组),比较2组病人围手术期资料、并发症及随访情况等资料。结果:腔镜组平均年龄较开放组年轻(P<0.05);腔镜组平均手术时间及术后第1天引流液量均较开放组多(P<0.01);腔镜组术中出血量比开放组少(P<0.01);术后第3天颈部VAS评分腔镜组较开放组低(P<0.05);中央区清扫后平均淋巴结数目腔镜组与开放组比较差异无统计学意义(P>0.05);2组病人术后住院时间、术后并发症比较差异无统计学意义(P>0.05);腔镜组术后美容满意度较高(P<0.01);随访3个月以上,均未见复发与转移。结论:免充气经腋窝入路腔镜下甲状腺微小乳头状癌手术安全可行,与开放手术相当,并具有较佳的美容效果。 Objective:To explore the surgical experience and curative effects of the axillary approach without inflation in the treatment of papillary thyroid microcarcinoma.Methods:A total of 80 patients with papillary thyroid microcarcinoma were divided into the endoscope group(35 cases treated with endoscopic surgery)and open group(45 cases treated with open surgery).The perioperative data,complications and following-up data were compared between two groups.Results:The average age in endoscope group was younger than that in open group(P<0.05),the average operation time and amount of drainage fluid on the first day after the operation in endoscope group were more than those in open group(P<0.01),and the intraoperative blood loss in endoscope group was less than that in open group(P<0.01).The neck VAS score in endoscope group was lower than that in open group on the third day after operation(P<0.05).The difference of the average number of lymph nodes after central dissection between two groups was not statistically significant(P>0.05).There was no statistical significance in the postoperative hospital stay and postoperative complications between two groups(P>0.05).The postoperative cosmetic satisfaction in endoscope group was higher than that in open group(P<0.01).All cases were followed up for more than 3 months,and no recurrence or metastasis case was found.Conclusions:The axillary approach without inflation in the treatment of papillary thyroid microcarcinoma is safe and feasible,has better cosmetic effects,and which is comparable to open surgery.
作者 甄卫东 王苏杭 彭德峰 陈春春 马小开 李玉龙 钱军 黄建康 ZHEN Wei-dong;WANG Su-hang;PENG De-feng;CHEN Chun-chun;MA Xiao-kai;LI Yu-long;QIAN Jun;HUANG Jian-kang(Department of Surgical Oncology,The First Affiliated Hospital of Bengbu Medical College,Bengbu Anhui 233004,China)
出处 《蚌埠医学院学报》 CAS 2021年第6期722-725,730,共5页 Journal of Bengbu Medical College
基金 蚌埠医学院第一附属医院高新技术项目(2015004)。
关键词 甲状腺微小乳头状癌 腔镜 腋窝入路 淋巴结清扫 papillary thyroid microcarcinoma laparoscopy axillary approach lymph node dissection
  • 相关文献

参考文献6

二级参考文献70

  • 1American Thyroid Association (ATA) Guidelines Taskforce on Thy- roid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, et al. Revised American thyroid association manage- ment guidelines for patients with thyroid nodules and differentiat- ed thyroid cancer[J]. Thyroid, 2009, 19(11):1167-1214.
  • 2Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid as- sociation management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid as- sociation guidelines task force on thyroid nodules and differentiat- ed thyroid cancer[J]. Thyroid, 2016, 26(1):1-133.
  • 3Tuttle RM, Haddad RI, Ball DW, et al. Thyroid carcinoma, version 2.2014[J]. J Natl Compr Canc Netw, 2014, 12(12):1671-1680.
  • 4Xing MZ. Molecular pathogenesis and mechanisms of thyroid can- cer[J]. Nat Rev Cancer, 2013, 13(3):184-199.
  • 5De Biase D, Gandolfi G, Ragazzi M, et al. TERT promoter mutations in papillary thyroid microcarcinomas[J]. Thyroid, 2015, 25(9):1013- 1019.
  • 6Ito Y, Miyauchi A, Inoue H, et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients[J]. World J Surg, 2010, 34(1):28-35.
  • 7Ito Y, Uruno T, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid [J]. Thyroid, 2003, 13(4):381-387.
  • 8Xing M, Alzahrani AS, Carson KA, et al. Association between BRAF V600E mutation and recurrence of papillary thyroid cancer[J]. J Clin Oncol, 2015, 33(1):42-50.
  • 9Jiang LH, Chen C, Tan Z, et al. Clinical characteristics related to central lymph node metastasis in cN0 papillary thyroid carcinoma: a retro- spective study of 916 patients[J]. Int J Endocrinol, 2014, 2014:385787.
  • 10Ito Y, Fukushima M, Higashiyama T, et al. Tumor size is the strongest predictor of microscopic lymph node metastasis and lymph node recurrence of NO papillary thyroid carcinoma[J]. Endocr J, 2013, 60 (1):113-117.

共引文献937

同被引文献122

引证文献10

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部